Neoadjuvant therapy in primary liver cancer: From the missing piece to a new paradigm

Authors

Institutions

Publication Details

Journal
Hepatology Communications
Published
2026-06-26
DOI
https://doi.org/10.1097/hc9.0000000000000977
Primary Topic
Hepatocellular Carcinoma Treatment and Prognosis
Type
article
Field-Weighted Citation Impact
0.00
Controls
|||
ALL TIME
JAN
FEB
MAR
APR
MAY
JUN
JUL
AUG
SEP
OCT
article

Neoadjuvant therapy in primary liver cancer: From the missing piece to a new paradigm

Haojie Jin, Kui Ming Chan, Z J Li
Hepatology Communications
Hepatocellular Carcinoma Treatment and Prognosis
article

Neoadjuvant therapy in primary liver cancer: From the missing piece to a new paradigm

Haojie Jin, Kui Ming Chan, Z J Li
article en

Abstract

No abstract available for this paper.
Hepatology CommunicationsVol. 10(7)
City University of Hong Kong (HK), Shanghai Jiao Tong University (CN), Renji Hospital (CN), Shanghai Cancer Institute (CN)
Openalex Percentile: Top 8%
Hepatocellular Carcinoma Treatment and Prognosis
DOIOpen Access PDFOpenAlex
AI Navigator

Ask Laika to Summarize, Analyze, and Connect papers live on the map.

Summarize Papers & Methodologies

Extract key findings, datasets, and comparative methods across publications.

Benchmark Rankings & Visual Analytics

Rank top research institutions, authors, funders, topics, and journals by Field-Weighted Citation Impact (FWCI) and paper volume with instant charts.

Connect Distant Disciplines

Bridge topological clusters on the map to find hidden collaborative intersections.

Neoadjuvant therapy in primary liver cancer: From the missing piece to a new paradigm — Haojie Jin, Kui Ming Chan, et al. · Hepatology Communications (2026) | TGRS Research Map | TGRS